Ameren Shareholders Endorse CEO's $14M Pay, Re-elect Board
Earnings James Calloway

Ameren Shareholders Endorse CEO's $14M Pay, Re-elect Board

Ameren shareholders approved CEO compensation of $14.06 million and re-elected the full board, with strong support for the say-on-pay resolution.

AEE
Warner Bros. Discovery Stock Trades Below Intrinsic Value Amid Merger Speculation
Markets Daniel Marsh

Warner Bros. Discovery Stock Trades Below Intrinsic Value Amid Merger Speculation

Warner Bros. Discovery shares trade at $27.10, roughly 10% below some intrinsic value estimates but above a cited fair value of $18.17. Analysts remain divided amid merger talks with Paramount and regulatory uncertainty.

WBD
Wall Street Rally Falters as Oil and Yields Weigh on Tech
Markets Daniel Marsh

Wall Street Rally Falters as Oil and Yields Weigh on Tech

U.S. stocks were mixed Monday as rising oil and Treasury yields pressured tech. The Nasdaq slid 0.5%, while energy stocks gained. Dominion Energy jumped 9.4% on merger news.

NVDA AMD NEE D REGN HD WMT USO GLD XLE XLK
XP Inc. Stock Slides on Q1 Results: Weaker Inflows and Retail Take Rate Dampen Buyback Enthusiasm
Earnings James Calloway

XP Inc. Stock Slides on Q1 Results: Weaker Inflows and Retail Take Rate Dampen Buyback Enthusiasm

XP Inc. shares dropped 3.78% in after-hours trading Monday after Q1 earnings showed higher profit but weaker net inflows and a lower retail take rate, offsetting a new buyback program.

XP
LiveRamp Surges on Publicis $2.5 Billion Cash Acquisition Offer
Technology Sarah Chen

LiveRamp Surges on Publicis $2.5 Billion Cash Acquisition Offer

LiveRamp shares soared after Publicis Groupe announced a $2.5 billion cash takeover, signaling a major bet on data collaboration for AI-powered marketing.

RAMP SPY QQQ
Agilysys Stock Surges on Record Revenue and Strong Fiscal 2027 Forecast
Earnings James Calloway

Agilysys Stock Surges on Record Revenue and Strong Fiscal 2027 Forecast

Agilysys shares surged 16.7% in after-hours trading following record fiscal Q4 revenue and a fiscal 2027 outlook that exceeded current sales, bucking a weaker tech market.

AGYS
Regeneron Plunges 10% on Melanoma Drug Trial Failure
Markets Daniel Marsh

Regeneron Plunges 10% on Melanoma Drug Trial Failure

Regeneron Pharmaceuticals shares dropped 9.8% Monday after its late-stage melanoma drug trial with fianlimab failed to meet its primary endpoint, missing statistical significance versus Merck's Keytruda.

REGN MRK BMY
Sunshine Biopharma Shares Swing Wildly After $6M Offering
Markets Daniel Marsh

Sunshine Biopharma Shares Swing Wildly After $6M Offering

Sunshine Biopharma shares experienced extreme volatility Monday after a $6M public offering, surging 516% before closing up 78% at $0.51.

SBFM
NextEra's $66.8B Dominion Deal Targets AI Data Center Demand
Markets Daniel Marsh

NextEra's $66.8B Dominion Deal Targets AI Data Center Demand

NextEra Energy agreed to acquire Dominion Energy in a $66.8B all-stock deal, sending Dominion shares up 9.4% as AI data centers drive power demand.

NEE D XLU
Zeta Global Soars 12% on OpenAI Advertising Pact
Technology Sarah Chen

Zeta Global Soars 12% on OpenAI Advertising Pact

Zeta Global shares jumped 12% on Monday after the company revealed an agreement to assist OpenAI with its advertising operations, outpacing a declining broader market.

ZETA SPY QQQ SNOW
ServiceNow Surges on Bullish AI Outlook from Bank of America
Technology Sarah Chen

ServiceNow Surges on Bullish AI Outlook from Bank of America

ServiceNow shares surged 8.8% Monday after Bank of America reinstated coverage with a Buy rating and $130 target, highlighting AI-driven workflow opportunities.

NOW CRM
Goosehead Insurance Shares Surge 12% After JPMorgan Target Cut
Markets Daniel Marsh

Goosehead Insurance Shares Surge 12% After JPMorgan Target Cut

Goosehead Insurance shares jumped 12% to $42.14, recovering from recent lows after JPMorgan cut its price target to $55. Q1 revenue rose 23% to $93.1M, with net income tripling.

GSHD JPM